DocGo Inc. (DCGO)
NASDAQ: DCGOHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DCGO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $17.32M
- Forward P/E
- 34.75
- EPS (TTM)
- -$1.83
- Dividend yield
- None
- 52-week range
- 0.167 – 1.10
- Day range
- 0.1683 – 0.1797
- Volume / Avg
- 1.02M / 729.51K
- Beta
- —
- Shares outstanding
- 98.99M
52-week range
DCGO stock today
DocGo (DCGO) closed at $0.175 on Nov 20, up 1.98% (+$0.0034), versus the S&P 500's 3.70% decline. Shares are 84.1% below their 52-week high of $1.10, set on Dec 4, 2025 and 4.8% above the 52-week low of $0.167, near the bottom of the past year's range. DCGO is down 80.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 81.9%.
DocGo has posted a net loss over the last twelve months (EPS of -$1.83), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About DocGo
Company profileDocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Lee Bienstock
- Headquarters
- New York, NY
- Employees
- 2,537
- IPO year
- 2020
- Website
- docgo.com
Financial highlights
Full financialsIn fiscal 2025, DocGo generated $322.2 million in revenue, down 47.7% from fiscal 2024, its first annual decline since 2024. DocGo reported a net loss of $182.4 million, compared with net income of $20.0 million a year earlier. Operating margin was -55.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $322.20M | $616.56M | $624.29M | $440.52M | $318.72M |
| Growth | -47.74% | -1.24% | +41.72% | +38.21% | +238.74% |
| Net income | $-182.40M | $19.99M | $6.86M | $34.58M | $23.74M |
| EPS (diluted) | $-1.84 | $0.18 | $0.06 | $0.34 | $0.25 |
Analyst forecast
ForecastConsensus (5 analysts)
buy
Avg. price target
$1.88+974.29%
- Strong buy 1
- Buy 1
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 9, 2026
- EPS actual vs est.
- $-0.17 vs $-0.04
- Surprise
- -325.00%
DCGO news
All DCGO newsDocGo peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CCMConcord Medical Services Holdings Limited ADR | 3.55 | -1.11% | $15.41M | vs DCGO |
| BMGLBasel Medical Group Ltd | 0.3832 | +20.01% | $5.20M | vs DCGO |
| ATPCAgape ATP Corporation | 1.16 | -15.94% | $1.16M | vs DCGO |
| BTSGUBrightSpring Health Services Inc. Tangible Equity Unit | 206.42 | -4.24% | — | vs DCGO |
| ALPSALPS Group Inc | 1.15 | -3.36% | $36.43M | vs DCGO |
| AIRSAirSculpt Technologies Inc. | 0.5907 | -9.72% | $43.67M | vs DCGO |
| EUDAEUDA Health Holdings Limited Class A | 15.96 | -7.69% | $47.79M | vs DCGO |
| NAKANakamoto Inc. | 3.44 | -15.89% | $63.11M | vs DCGO |
Indexes, lists and sector
DocGo stock FAQ
What is DocGo's stock price today?
DCGO last traded at $0.175 as of Nov 20, 4:00 PM EST, up 1.98% on the day. Prices are delayed at least 15 minutes.
Who is DocGo's CEO?
Mr. Lee Bienstock is the chief executive officer of DocGo Inc., which has about 2,537 employees.
What is the DCGO 52-week high?
The 52-week high for DCGO is $1.10 and the 52-week low is $0.167. The stock is currently 84.1% below its high.